• ARCA Biopharma Inc., of Broomfield, Colo., priced a public offering that includes approximately 125,000 shares of Series A convertible preferred stock and warrants to purchase approximately 6.25 million shares of common stock, with each share of preferred stock and related warrants priced at $160.